Organization
WinSanTor
4 clinical trials
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Study of Topical Pirenzepine or Placebo for the Prevention of Dose Limiting Chemotherapy Induced Peripheral Neuropathy in Oncology Patients Administered Carboplatin and PaclitaxelStatus: Recruiting, Estimated PCD: 2024-04-26
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Parallel, 24-Week, Phase 2a Study of Topical Pirenzepine (WST-057) or Placebo in Type 2 Diabetic Patients With Peripheral NeuropathyStatus: Completed, Estimated PCD: 2021-12-15
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Parallel, 12-week, Phase 2a Study of Topical Pirenzepine (WST-057) or Placebo in Type 2 Diabetes Mellitus Patients With Painful Peripheral NeuropathyStatus: Completed, Estimated PCD: 2022-12-08
Clinical trial
A 16-Week Phase 2a Study of Topical Pirenzepine (WST-057) or Placebo to Treat HIV-Associated Distal Sensory Polyneuropathy (DSP) in Patients With HIV (PWH)Status: Completed, Estimated PCD: 2023-01-18